Predictors of glycemic control among type 1 pediatric diabetes patients-Northeast Ethiopia

Hiwot Adege1, Gedefaw Getnet2, Abyou Seyfu Ambaye3

  • 1School of Medicine, College of Medicine and Health Science, Wollo University, Dessie, Ethiopia.

Insights

Pediatric type 1 diabetes patients often have poor glycemic control. This highlights the need for targeted interventions to prevent long-term diabetes complications in children.

Area of Science:

  • Endocrinology
  • Metabolic Disorders
  • Pediatric Health

Background:

  • Type 1 diabetes mellitus is a prevalent endocrine-metabolic disorder in children and adolescents globally.
  • Effective management of pediatric type 1 diabetes is crucial for preventing long-term complications.

Purpose of the Study:

  • To assess glycemic control levels in pediatric patients with type 1 diabetes.
  • To identify predictors of glycemic control in this population.

Main Methods:

  • A prospective cross-sectional study was conducted at Dessie Comprehensive Specialized Hospital, Northeast Ethiopia.
  • Data from 203 pediatric patients with type 1 diabetes were analyzed using bivariate and multivariate methods.

Main Results:

  • Over half of the patients (52.7%) exhibited good glycemic control, while 47.3% had poor control.
  • Factors associated with poor glycemic control included longer diabetes duration, comorbid conditions, and diabetes-related complications.
  • Being a third-born child was also a significant factor.

Conclusions:

  • Glycemic control is a significant challenge for pediatric patients with type 1 diabetes.
  • These children require specialized attention to mitigate the long-term adverse effects of diabetes.
Abstract

Related Concept Videos

Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.1K
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
2.4K
Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
232
Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
499
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
852
Insulin: Dosing Regimen and Adverse Effects01:16

Insulin: Dosing Regimen and Adverse Effects

Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
141